학술논문
Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor
Document Type
Article
Author
Source
In Journal of Diabetes and Its Complications January 2024 38(1)
Subject
Language
ISSN
1056-8727